Second Quarter Operating Highlights: Consolidated net sales of $823 million in the second quarter of 2017 increased by $38 million, or 5 percent, compared to $785 million for the 2016 second quarter. Revenue growth in the paper and packaging segment resulted from higher prices and volume. The Company's average mill selling price of $661 per ton in the second quarter of 2017 increased by $37 per ton, or about 6 percent, compared to the second quarter of 2016 due to higher domestic and export containerboard prices, higher specialty paper prices and a more favorable product mix. Revenues in the distribution segment increased $8 million, mainly due to higher prices. Operating income of $41 million for the 2017 second quarter decreased by $2 million, or 5 percent, compared to the 2016 second quarter. Click Read More below for additional details.
A new set of resources released by the California Department of Public Health (CDPH) offers a checklist with the Dos and Don’ts of cannabis packaging in the state, along with labeling instructions.
- Package manufactured cannabis products prior to transfer to a distributor as a finished product. Cannabis flower may be packaged by a cultivator, manufacturer or distributor.
- If a product has multiple layers of packaging, the packaging requirements can be fulfilled using any one of those layers.
- Cannot imitate packaging used for non-cannabis food products or products typically marketed to children.
The four main criteria for a package to meet are tamper evidence, child-resistance, resealability (for products with multiple uses) and opaque packaging for edibles.
Only edibles must be packaged in “lifetime” child-resistant packaging (child-resistant after opening and reclosing), while other forms of products must be initially child-resistant, upon first opening.
Additionally, a labeling checklist specifies what info can and cannot be included. The product’s county of origin can not appear anywhere on the label unless 100% of the cannabis in the product was grown there. Labels are also forbidden from making unproven health claims.